Identification of CD19 as a shared biomarker via PPARγ/β-catenin/Wnt3a pathway linking psoriasis and major depressive disorder
Lists
Only you see this
Abstract
CD19 may serve as a common biomarker or therapeutic target of psoriasis and MDD via PPARγ/β-catenin/Wnt3a pathway.
BibTeX
@article{zhou2024identification,
author = {Bin Zhou and Ting Wu and Haitao Li and Jiahao Yang and Zhujun Ma and Yunli Ling and Hanying Ma and Changzheng Huang},
title = {{Identification of CD19 as a shared biomarker via PPARγ/β-catenin/Wnt3a pathway linking psoriasis and major depressive disorder}},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.08.159},
}Loading related content...